[1]王福星.醒脑静注射液治疗急性重症脑血管病的临床疗效[J].医学信息,2020,33(18):162-163.[doi:10.3969/j.issn.1006-1959.2020.18.054]
　WANG Fu-xing.Clinical Observation of Xingnaojing Injection in the Treatment of Acute Severe Cerebrovascular Disease[J].Medical Information,2020,33(18):162-163.[doi:10.3969/j.issn.1006-1959.2020.18.054]
点击复制

醒脑静注射液治疗急性重症脑血管病的临床疗效()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年18期
页码:
162-163
栏目:
中医中药
出版日期:
2020-09-15

文章信息/Info

Title:
Clinical Observation of Xingnaojing Injection in the Treatment of Acute Severe Cerebrovascular Disease
文章编号:
1006-1959（2020）18-0162-02
作者:
王福星
（天津市东丽区东丽医院神经外科，天津 300300）
Author(s):
WANG Fu-xing
(Department of Neurosurgery,Dongli Hospital,Dongli District,Tianjin 300300,China)
关键词:
醒脑静注射液; 神经功能缺损; 脑血管病
Keywords:
Xingnaojing injection; Neurological deficit; Cerebrovascular disease
分类号:
R971
DOI:
10.3969/j.issn.1006-1959.2020.18.054
文献标志码:
A
摘要:
目的 观察醒脑静注射液治疗急性重症脑血管病的临床疗效。方法 选取2018年7月~2019年7月在我院诊治的134例急性重症脑血管病患者为研究对象，采用随机数字表法分为对照组和观察组，各67例。对照组采用常规治疗，观察组在对照组基础上采用醒脑静注射液治疗，比较两组临床治疗总有效率、神经功能缺损评分、格拉斯哥昏迷（GCS）评分及临床不良反应发生情况。结果 观察组临床治疗总有效率为94.02%，高于对照组的80.59%（P＜0.05）；治疗后两组神经功能缺损评分均低于治疗前，且观察组低于对照组（P＜0.05）；治疗后两组GCS评分均低于治疗前，且观察组低于对照组（P＜0.05）；观察组临床不良反应发生率与对照组比较，差异无统计学意义（P＞0.05）。结论 醒脑静注射液治疗急性重症脑血管病疗效显著，总有效率高，可显著改善患者神经功能缺损，降低GCS评分，且临床不良反应少。
Abstract:
Objective To observe the clinical efficacy of Xingnaojing injection in the treatment of acute severe cerebrovascular disease.Methods A total of 134 patients with acute severe cerebrovascular disease diagnosed and treated in our hospital from July 2018 to July 2019 were selected as the research objects. They were divided into control group and observation group by random number table method, with 67 cases in each group. The control group was treated with conventional treatment, and the observation group was treated with Xingnaojing injection on the basis of the control group. The total effective rate of clinical treatment, neurological deficit score, Glasgow coma (GCS) score and the occurrence of clinical adverse reactions were compared between the two groups.Results The total effective rate of clinical treatment in the observation group was 94.02%, which was higher than 80.59% in the control group(P＜0.05); the scores of neurological deficits in the two groups after treatment were lower than those before treatment, and the observation group was lower in the control group(P＜0.05); after treatment, the GCS scores of the two groups were lower than before treatment, and the observation group was lower than the control group(P＜0.05); clinical adverse reactions in the observation group compared with the control group, the incidence rate was not statistically significant (P>0.05).Conclusion Xingnaojing injection had a significant curative effect in the treatment of acute severe cerebrovascular disease. The total effective rate was high. It could significantly improve patients’ neurological deficits, reduce GCS scores, and had fewer clinical adverse reactions.

参考文献/References:

[1]钟有.醒脑静注射液联合纳洛酮治疗急性重症脑血管病的疗效观察[J].实用心脑肺血管病杂志,2014,22(12):89-90.[2]Behrouz R,Hafeez S,Mutgi SA.Intensive blood pressure reduction in acute intracerebral hemorrhage:A meta-analysis[J].Neurology,2015,84(24):2464.[3]石芳,李芝静,张春娟,等.丹参联合醒脑静治疗高血压性脑出血的疗效观察[J].陕西中医,2015,36(3):276-278.[4]宋纪宁,梁日晶,薛振生.复方麝香注射液治疗高血压性脑出血300例[J].陕西中医,2014,35(6):663-664.[5]杨震，李安泰.醒脑静注射液治疗急性重症脑血管病效果观察[J].吉林医学,2014(16):3529-3530.

相似文献/References:

[1]陈 曦,刘 楠,张洪淞.尤瑞克林治疗急性脑梗死患者的临床效果[J].医学信息,2019,32(12):156.[doi:10.3969/j.issn.1006-1959.2019.12.052]
　CHEN Xi,LIU Nan,ZHANG Hong-song.Clinical Effect of Ureklin in Patients with Acute Cerebral Infarction[J].Medical Information,2019,32(18):156.[doi:10.3969/j.issn.1006-1959.2019.12.052]
[2]罗雷雷.醒脑静治疗急性脑出血的疗效及对血清hs-CRP和NSE的影响[J].医学信息,2019,32(23):149.[doi:10.3969/j.issn.1006-1959.2019.23.046]
　LUO Lei-lei.Effect of Xingnaojing on Acute Cerebral Hemorrhage and its Effect on Serum hs-CRP and NSE[J].Medical Information,2019,32(18):149.[doi:10.3969/j.issn.1006-1959.2019.23.046]
[3]王 娜.急诊护理流程对脑梗死溶栓治疗患者神经功能缺损及日常生活能力的影响[J].医学信息,2019,32(23):180.[doi:10.3969/j.issn.1006-1959.2019.23.059]
　WANG Na.Effect of Emergency Nursing Procedure on Neurological Deficit and Daily Living Ability in Patients with Cerebral Infarction Treated with Thrombolytic Therapy[J].Medical Information,2019,32(18):180.[doi:10.3969/j.issn.1006-1959.2019.23.059]
[4]李 鹏,李爱歆.多塞平治疗脑卒中后抑郁状态及对神经功能缺损的康复影响[J].医学信息,2020,33(15):142.[doi:10.3969/j.issn.1006-1959.2020.15.044]
　LI Peng,LI Ai-xin.Doxepin in the Treatment of Post-stroke Depression and Its Effecton Rehabilitation of Neurological Deficits[J].Medical Information,2020,33(18):142.[doi:10.3969/j.issn.1006-1959.2020.15.044]
[5]李桂华,曹本玥.PA、hs-CRP、ox-LDL及H-FABP与ACI患者神经功能缺损程度的关系[J].医学信息,2021,34(16):112.[doi:10.3969/j.issn.1006-1959.2021.16.030]
　LI Gui-hua,CAO Ben-yue.The Relationship Between PA,hs-CRP,ox-LDL,H-FABP and the Degree of Neurological Deficit in Patients with ACI[J].Medical Information,2021,34(18):112.[doi:10.3969/j.issn.1006-1959.2021.16.030]
[6]赵爱云,杨 勇,罗 云,等.干预肠道菌群联合序贯治疗对缺血性脑卒中患者神经功能的影响[J].医学信息,2022,35(02):133.[doi:10.3969/j.issn.1006-1959.2022.02.033]
　ZHAO Ai-yun,YANG Yong,LUO Yun,et al.Effect of Intervention of Intestinal Flora Combined with Sequential Therapyon Neurological Function in Patients with Ischemic Stroke[J].Medical Information,2022,35(18):133.[doi:10.3969/j.issn.1006-1959.2022.02.033]
[7]娄永忠,王 涛,郭筱菲,等.丁苯酞对缺血性脑卒中患者神经功能缺损程度影响的临床研究[J].医学信息,2022,35(04):115.[doi:10.3969/j.issn.1006-1959.2022.04.028]
　LOU Yong-zhong,WANG Tao,GUO Xiao-fei,et al.Clinical Study on the Effect of Butylphthalide on Neurological Deficits in Patients with Ischemic Stroke[J].Medical Information,2022,35(18):115.[doi:10.3969/j.issn.1006-1959.2022.04.028]

更新日期/Last Update: 1900-01-01